Do analysts recommend ZEPP or SILC?

Zepp Health currently has a consensus price target of $56.28, suggesting a potential upside of 1,143.76%. Given Zepp Health's stronger consensus rating and higher probable upside, equities research analysts clearly believe Zepp Health is more favorable than Silicom. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zepp Health 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Silicom 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings & valuation, ZEPP or SILC?

Silicom has lower revenue, but higher earnings than Zepp Health. Silicom is trading at a lower price-to-earnings ratio than Zepp Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Zepp Health $271.91M 0.24 -$40.07M -$2.52 N/A Silicom $61.93M 3.79 -$11.48M -$1.93 N/A

Is ZEPP or SILC more profitable?

Zepp Health has a net margin of -14.70% compared to Silicom's net margin of -16.57%. Silicom's return on equity of -9.30% beat Zepp Health's return on equity. Company Net Margins Return on Equity Return on Assets Zepp Health -14.70% -15.64% -6.03% Silicom -16.57% -9.30% -7.24%

Does the media refer more to ZEPP or SILC?

In the previous week, Zepp Health and Zepp Health both had 3 articles in the media. Silicom's average media sentiment score of 0.29 beat Zepp Health's score of 0.00 indicating that Silicom is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zepp Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Silicom 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate ZEPP or ALOT?

Zepp Health presently has a consensus price target of $56.28, indicating a potential upside of 1,143.76%. Given Zepp Health's stronger consensus rating and higher possible upside, analysts plainly believe Zepp Health is more favorable than AstroNova. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zepp Health 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 AstroNova 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is ZEPP or ALOT more profitable?

AstroNova has a net margin of -0.88% compared to Zepp Health's net margin of -14.70%. AstroNova's return on equity of 2.94% beat Zepp Health's return on equity. Company Net Margins Return on Equity Return on Assets Zepp Health -14.70% -15.64% -6.03% AstroNova -0.88% 2.94% 1.61%

Which has preferable earnings & valuation, ZEPP or RDCM?

Radcom has lower revenue, but higher earnings than Zepp Health. Zepp Health is trading at a lower price-to-earnings ratio than Radcom, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Zepp Health $271.91M 0.24 -$40.07M -$2.52 N/A Radcom $71.49M 3.14 $11.99M $0.75 17.91

Is ZEPP or RDCM more profitable?

Radcom has a net margin of 17.18% compared to Zepp Health's net margin of -14.70%. Radcom's return on equity of 11.68% beat Zepp Health's return on equity. Company Net Margins Return on Equity Return on Assets Zepp Health -14.70% -15.64% -6.03% Radcom 17.18% 11.68% 9.16%

Does the media favor ZEPP or RDCM?

In the previous week, Zepp Health and Zepp Health both had 3 articles in the media. Radcom's average media sentiment score of 0.93 beat Zepp Health's score of 0.00 indicating that Radcom is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zepp Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Radcom 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings and valuation, QMCO or ZEPP?

Zepp Health has lower revenue, but higher earnings than Quantum. Zepp Health is trading at a lower price-to-earnings ratio than Quantum, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Quantum $279.58M 0.61 -$115.09M -$8.05 N/A Zepp Health $271.91M 0.24 -$40.07M -$2.52 N/A

Is QMCO or ZEPP more profitable?

Zepp Health has a net margin of -14.70% compared to Quantum's net margin of -36.14%. Quantum's return on equity of 0.00% beat Zepp Health's return on equity. Company Net Margins Return on Equity Return on Assets Quantum -36.14% N/A -18.94% Zepp Health -14.70% -15.64% -6.03%

Does the media prefer QMCO or ZEPP?

In the previous week, Quantum had 6 more articles in the media than Zepp Health. MarketBeat recorded 9 mentions for Quantum and 3 mentions for Zepp Health. Quantum's average media sentiment score of 0.71 beat Zepp Health's score of 0.00 indicating that Quantum is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quantum 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Zepp Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher valuation & earnings, VTIX or ZEPP?

Virtuix has higher earnings, but lower revenue than Zepp Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Virtuix $4.25M 18.90 N/A N/A N/A Zepp Health $271.91M 0.24 -$40.07M -$2.52 N/A

Is VTIX or ZEPP more profitable?

Virtuix has a net margin of 0.00% compared to Zepp Health's net margin of -14.70%. Virtuix's return on equity of 0.00% beat Zepp Health's return on equity. Company Net Margins Return on Equity Return on Assets Virtuix N/A N/A N/A Zepp Health -14.70% -15.64% -6.03%

Does the media favor VTIX or ZEPP?

In the previous week, Virtuix had 4 more articles in the media than Zepp Health. MarketBeat recorded 7 mentions for Virtuix and 3 mentions for Zepp Health. Virtuix's average media sentiment score of 1.05 beat Zepp Health's score of 0.00 indicating that Virtuix is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Virtuix 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Zepp Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Zepp Health (ZEPP) Competitors

$4.53 -0.10 (-2.06%)

Closing price 06/26/2026 03:59 PM Eastern

Extended Trading

$4.51 -0.01 (-0.22%)

As of 06/26/2026 04:34 PM Eastern

Compare

ZEPP vs. SILC, ALOT, RDCM, QMCO, and VTIX

Should you buy Zepp Health stock or one of its competitors? MarketBeat compares Zepp Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Zepp Health include Silicom (SILC), AstroNova (ALOT), Radcom (RDCM), Quantum (QMCO), and Virtuix (VTIX). These companies are all part of the "computer hardware" industry.

How does Zepp Health compare to Silicom?

Zepp Health (NYSE:ZEPP) and Silicom (NASDAQ:SILC) are both small-cap computer hardware companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation, media sentiment and analyst recommendations.

Zepp Health currently has a consensus price target of $56.28, suggesting a potential upside of 1,143.76%. Given Zepp Health's stronger consensus rating and higher probable upside, equities research analysts clearly believe Zepp Health is more favorable than Silicom.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zepp Health	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Silicom	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Zepp Health has a beta of 1.78, suggesting that its stock price is 78% more volatile than the broader market. Comparatively, Silicom has a beta of 1.58, suggesting that its stock price is 58% more volatile than the broader market.

Zepp Health has a net margin of -14.70% compared to Silicom's net margin of -16.57%. Silicom's return on equity of -9.30% beat Zepp Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zepp Health	-14.70%	-15.64%	-6.03%
Silicom	-16.57%	-9.30%	-7.24%

In the previous week, Zepp Health and Zepp Health both had 3 articles in the media. Silicom's average media sentiment score of 0.29 beat Zepp Health's score of 0.00 indicating that Silicom is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zepp Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Silicom	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Silicom has lower revenue, but higher earnings than Zepp Health. Silicom is trading at a lower price-to-earnings ratio than Zepp Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zepp Health	$271.91M	0.24	-$40.07M	-$2.52	N/A
Silicom	$61.93M	3.79	-$11.48M	-$1.93	N/A

52.6% of Zepp Health shares are owned by institutional investors. Comparatively, 52.9% of Silicom shares are owned by institutional investors. 36.0% of Zepp Health shares are owned by insiders. Comparatively, 25.4% of Silicom shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Zepp Health beats Silicom on 9 of the 15 factors compared between the two stocks.

How does Zepp Health compare to AstroNova?

Zepp Health (NYSE:ZEPP) and AstroNova (NASDAQ:ALOT) are both small-cap computer hardware companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, media sentiment, risk, earnings and profitability.

AstroNova has lower revenue, but higher earnings than Zepp Health. AstroNova is trading at a lower price-to-earnings ratio than Zepp Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zepp Health	$271.91M	0.24	-$40.07M	-$2.52	N/A
AstroNova	$150.51M	1.47	-$2.38M	-$0.18	N/A

Zepp Health has a beta of 1.78, indicating that its stock price is 78% more volatile than the broader market. Comparatively, AstroNova has a beta of 0.99, indicating that its stock price is 1% less volatile than the broader market.

Zepp Health presently has a consensus price target of $56.28, indicating a potential upside of 1,143.76%. Given Zepp Health's stronger consensus rating and higher possible upside, analysts plainly believe Zepp Health is more favorable than AstroNova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zepp Health	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
AstroNova	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

52.6% of Zepp Health shares are held by institutional investors. Comparatively, 43.0% of AstroNova shares are held by institutional investors. 36.0% of Zepp Health shares are held by company insiders. Comparatively, 12.6% of AstroNova shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

AstroNova has a net margin of -0.88% compared to Zepp Health's net margin of -14.70%. AstroNova's return on equity of 2.94% beat Zepp Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zepp Health	-14.70%	-15.64%	-6.03%
AstroNova	-0.88%	2.94%	1.61%

In the previous week, Zepp Health had 2 more articles in the media than AstroNova. MarketBeat recorded 3 mentions for Zepp Health and 1 mentions for AstroNova. AstroNova's average media sentiment score of 1.87 beat Zepp Health's score of 0.00 indicating that AstroNova is being referred to more favorably in the news media.

Company	Overall Sentiment
Zepp Health	Neutral
AstroNova	Very Positive

Summary

Zepp Health beats AstroNova on 9 of the 16 factors compared between the two stocks.

How does Zepp Health compare to Radcom?

Zepp Health (NYSE:ZEPP) and Radcom (NASDAQ:RDCM) are both small-cap computer hardware companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, earnings, analyst recommendations, media sentiment, institutional ownership, dividends and valuation.

Zepp Health has a beta of 1.78, meaning that its share price is 78% more volatile than the broader market. Comparatively, Radcom has a beta of 0.71, meaning that its share price is 29% less volatile than the broader market.

In the previous week, Zepp Health and Zepp Health both had 3 articles in the media. Radcom's average media sentiment score of 0.93 beat Zepp Health's score of 0.00 indicating that Radcom is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zepp Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Radcom	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Zepp Health currently has a consensus price target of $56.28, suggesting a potential upside of 1,143.76%. Radcom has a consensus price target of $18.00, suggesting a potential upside of 34.03%. Given Zepp Health's higher possible upside, analysts clearly believe Zepp Health is more favorable than Radcom.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zepp Health	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Radcom	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Radcom has a net margin of 17.18% compared to Zepp Health's net margin of -14.70%. Radcom's return on equity of 11.68% beat Zepp Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zepp Health	-14.70%	-15.64%	-6.03%
Radcom	17.18%	11.68%	9.16%

Radcom has lower revenue, but higher earnings than Zepp Health. Zepp Health is trading at a lower price-to-earnings ratio than Radcom, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zepp Health	$271.91M	0.24	-$40.07M	-$2.52	N/A
Radcom	$71.49M	3.14	$11.99M	$0.75	17.91

52.6% of Zepp Health shares are owned by institutional investors. Comparatively, 48.3% of Radcom shares are owned by institutional investors. 36.0% of Zepp Health shares are owned by company insiders. Comparatively, 69.0% of Radcom shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Radcom beats Zepp Health on 10 of the 14 factors compared between the two stocks.

How does Zepp Health compare to Quantum?

Quantum (NASDAQ:QMCO) and Zepp Health (NYSE:ZEPP) are both small-cap computer hardware companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, media sentiment, dividends, valuation and profitability.

In the previous week, Quantum had 6 more articles in the media than Zepp Health. MarketBeat recorded 9 mentions for Quantum and 3 mentions for Zepp Health. Quantum's average media sentiment score of 0.71 beat Zepp Health's score of 0.00 indicating that Quantum is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Quantum	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Zepp Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Quantum presently has a consensus target price of $17.67, suggesting a potential upside of 51.65%. Zepp Health has a consensus target price of $56.28, suggesting a potential upside of 1,143.76%. Given Zepp Health's higher probable upside, analysts plainly believe Zepp Health is more favorable than Quantum.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quantum	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Zepp Health	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Zepp Health has a net margin of -14.70% compared to Quantum's net margin of -36.14%. Quantum's return on equity of 0.00% beat Zepp Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quantum	-36.14%	N/A	-18.94%
Zepp Health	-14.70%	-15.64%	-6.03%

Quantum has a beta of 2.97, suggesting that its share price is 197% more volatile than the broader market. Comparatively, Zepp Health has a beta of 1.78, suggesting that its share price is 78% more volatile than the broader market.

63.7% of Quantum shares are held by institutional investors. Comparatively, 52.6% of Zepp Health shares are held by institutional investors. 0.9% of Quantum shares are held by company insiders. Comparatively, 36.0% of Zepp Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Zepp Health has lower revenue, but higher earnings than Quantum. Zepp Health is trading at a lower price-to-earnings ratio than Quantum, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quantum	$279.58M	0.61	-$115.09M	-$8.05	N/A
Zepp Health	$271.91M	0.24	-$40.07M	-$2.52	N/A

Summary

Quantum beats Zepp Health on 10 of the 16 factors compared between the two stocks.

How does Zepp Health compare to Virtuix?

Virtuix (NASDAQ:VTIX) and Zepp Health (NYSE:ZEPP) are both small-cap computer hardware companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, analyst recommendations, media sentiment, valuation and profitability.

Virtuix has a net margin of 0.00% compared to Zepp Health's net margin of -14.70%. Virtuix's return on equity of 0.00% beat Zepp Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Virtuix	N/A	N/A	N/A
Zepp Health	-14.70%	-15.64%	-6.03%

52.6% of Zepp Health shares are held by institutional investors. 36.0% of Zepp Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Virtuix has higher earnings, but lower revenue than Zepp Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Virtuix	$4.25M	18.90	N/A	N/A	N/A
Zepp Health	$271.91M	0.24	-$40.07M	-$2.52	N/A

In the previous week, Virtuix had 4 more articles in the media than Zepp Health. MarketBeat recorded 7 mentions for Virtuix and 3 mentions for Zepp Health. Virtuix's average media sentiment score of 1.05 beat Zepp Health's score of 0.00 indicating that Virtuix is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Virtuix	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Zepp Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Virtuix presently has a consensus price target of $11.00, indicating a potential upside of 294.27%. Zepp Health has a consensus price target of $56.28, indicating a potential upside of 1,143.76%. Given Zepp Health's higher possible upside, analysts clearly believe Zepp Health is more favorable than Virtuix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Virtuix	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Zepp Health	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Virtuix beats Zepp Health on 6 of the 10 factors compared between the two stocks.

Get Zepp Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ZEPP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ZEPP vs. The Competition

Export

Metric	Zepp Health	MEDICAL INFO SYS Industry	Medical Sector	NYSE Exchange
Market Cap	$67.82M	$1.62B	$6.71B	$23.23B
Dividend Yield	N/A	N/A	2.67%	4.10%
P/E Ratio	-1.80	79.61	25.77	31.64
Price / Sales	0.24	7.68	555.19	16.02
Price / Cash	N/A	23.86	46.99	24.58
Price / Book	0.31	5.56	10.77	4.74
Net Income	-$40.07M	-$54.76M	$3.57B	$1.07B
7 Day Performance	-5.04%	-0.06%	3.17%	0.99%
1 Month Performance	-48.47%	-0.65%	1.86%	0.86%
1 Year Performance	77.87%	2.25%	34.38%	25.19%

Zepp Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ZEPP Zepp Health	1.8136 of 5 stars	$4.53 -2.1%	$56.28 +1,143.8%	+65.1%	$67.82M	$271.91M	N/A	1,230	News Coverage Analyst Downgrade Gap Down
SILC Silicom	0.4565 of 5 stars	$41.90 -6.8%	N/A	+163.6%	$238.93M	$61.93M	N/A	320	Short Interest Increase Gap Down
ALOT AstroNova	1.0947 of 5 stars	$28.43 +0.0%	N/A	+206.8%	$220.33M	$150.51M	N/A	340	Positive News
RDCM Radcom	4.0155 of 5 stars	$12.77 -0.1%	$18.00 +41.0%	+0.2%	$213.44M	$71.49M	17.00	280
QMCO Quantum	3.1794 of 5 stars	$13.68 -2.6%	$17.67 +29.1%	+28.2%	$199.94M	$274.06M	N/A	900	Trending News Analyst Forecast Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ZEPP) was last updated on 6/27/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Zepp Health (ZEPP) Competitors